155 related articles for article (PubMed ID: 3155985)
1. Release of prostaglandin E2 and beta-endorphin-like immunoreactivity from rat adenohypophysis in vitro: variations after adrenalectomy or lesions of the paraventricular nuclei.
Knepel W; Vlaskovska M; Meyer DK
Brain Res; 1985 Feb; 326(1):87-94. PubMed ID: 3155985
[TBL] [Abstract][Full Text] [Related]
2. Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor.
Vlaskovska M; Hertting G; Knepel W
Endocrinology; 1984 Sep; 115(3):895-903. PubMed ID: 6204854
[TBL] [Abstract][Full Text] [Related]
3. Beta-endorphin and adrenocorticotropin release from rat adenohypophysis in vitro: evidence for local modulation by arachidonic acid metabolites of the cyclooxygenase and lipoxygenase pathway.
Vlaskovska M; Knepel W
Neuroendocrinology; 1984 Oct; 39(4):334-42. PubMed ID: 6092988
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by prostaglandin E2 of the release of vasopressin and beta-endorphin from rat pituitary neurointermediate lobe or medial basal hypothalamus in vitro.
Knepel W; Nutto D; Vlaskovska M; Kittel C
J Endocrinol; 1985 Aug; 106(2):189-95. PubMed ID: 3160802
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of adrenocorticotropin/beta-endorphin release by synthetic ovine corticotropin-releasing factor in vitro. Enhancement by various vasopressin analogs.
Knepel W; Homolka L; Vlaskovska M; Nutto D
Neuroendocrinology; 1984 May; 38(5):344-50. PubMed ID: 6328345
[TBL] [Abstract][Full Text] [Related]
6. Adrenalectomy and experimental hypercorticalism modulate the basal, corticotropin-releasing-hormone- and arginine-vasopressin-stimulated release of hypothalamic beta-endorphin.
Patchev VK; Racké K; Almeida OF
Neuroendocrinology; 1991 Aug; 54(2):111-7. PubMed ID: 1766548
[TBL] [Abstract][Full Text] [Related]
7. Effect of prostaglandin E2 on ACTH and beta-endorphin release from rat adenohypophysis in vitro after secretagogues which can mimic various first or second messengers.
Knepel W; Götz D
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):149-55. PubMed ID: 3018594
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin release from rat medial basal hypothalamus in vitro after adrenalectomy or lesions of the paraventricular nuclei.
Knepel W; Nutto D; Meyer DK; Vlaskovska M
Neurosci Lett; 1984 Aug; 48(3):321-6. PubMed ID: 6091001
[TBL] [Abstract][Full Text] [Related]
9. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat by lipocortin 1 and glucocorticoids: a role for lipocortin 1 in the feedback inhibition of CRF-41 release?
Loxley HD; Cowell AM; Flower RJ; Buckingham JC
Neuroendocrinology; 1993 May; 57(5):801-14. PubMed ID: 8413817
[TBL] [Abstract][Full Text] [Related]
11. Arginine8 vasopressin potentiates the beta-endorphin-releasing activity of ovine corticotropin-releasing factor (oCRF) in vitro.
Culler MD; Turkelson CM; Thomas CR; Arimura A
Proc Soc Exp Biol Med; 1983 Jun; 173(2):264-9. PubMed ID: 6306671
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of hypothalamic paraventricular lesion on CRF content and stimulated ACTH secretion.
Makara GB; Stark E; Kapocs G; Antoni FA
Am J Physiol; 1986 Mar; 250(3 Pt 1):E319-24. PubMed ID: 3006511
[TBL] [Abstract][Full Text] [Related]
13. The concentration of arginine vasopressin in pituitary stalk plasma of the rat after adrenalectomy or morphine.
Koenig JI; Meltzer HY; Devane GD; Gudelsky GA
Endocrinology; 1986 Jun; 118(6):2534-9. PubMed ID: 2938937
[TBL] [Abstract][Full Text] [Related]
14. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
15. Onset of glucocorticoid responsiveness of anterior pituitary corticotrophs during development is scheduled by corticotropin-releasing factor.
Grino M; Burgunder JM; Eskay RL; Eiden LE
Endocrinology; 1989 Jun; 124(6):2686-92. PubMed ID: 2524376
[TBL] [Abstract][Full Text] [Related]
16. Distributions of pro-vasopressin expressing and pro-vasopressin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalectomized rats.
Whitnall MH
J Comp Neurol; 1988 Sep; 275(1):13-28. PubMed ID: 3262632
[TBL] [Abstract][Full Text] [Related]
17. A two-step mechanism by which corticotropin-releasing hormone releases hypothalamic beta-endorphin: the role of vasopressin and G-proteins.
Burns G; Almeida OF; Passarelli F; Herz A
Endocrinology; 1989 Sep; 125(3):1365-72. PubMed ID: 2527150
[TBL] [Abstract][Full Text] [Related]
18. Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: a marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin.
Antoni FA; Fink G; Sheward WJ
J Endocrinol; 1990 May; 125(2):175-83. PubMed ID: 2373973
[TBL] [Abstract][Full Text] [Related]
19. Effects of pituitary beta-endorphin secretagogues on the concentration of beta-endorphin in rat cerebrospinal fluid: evidence for a role of vasopressin in the regulation of brain beta-endorphin release.
Barna I; Sweep CG; Veldhuis HD; Wiegant VM; De Wied D
Neuroendocrinology; 1990 Jan; 51(1):104-10. PubMed ID: 2137562
[TBL] [Abstract][Full Text] [Related]
20. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
Ogilvie KM; Lee S; Rivier C
Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
